With the help of additional investors, FutureCure Health, a healthcare technology business that specializes in super-specialty care, raised Rs 104 crore ($11.5 million) in a funding round headed by Carnelian Asset Management LLP.

Key Highlights

• FutureCure Health raises Rs 104 crore funding round led by Carnelian Asset Management to accelerate growth plans.
• Capital infusion will support expansion, strengthen operations, and enhance healthcare service delivery across key markets.

The fundraising comes after a previous $4 million investment in 2022 that was supported by Unicorn India Ventures, RVCF Ventures, and Kotak Alternate Asset Management.

According to a press statement from FutureCure Health, the additional funding will be used to increase access to vertigo diagnosis and treatment.

FutureCure, which was co-founded in 2015 by Rajneesh and Anita Bhandari, operates a chain of vertigo and dizziness diagnostic and rehabilitation clinics as well as NeuroEquilibrium, a fully owned subsidiary. In contrast to traditional methods, NeuroEquilibrium concentrates on determining the underlying cause of vertigo, whether it originates from the brain, inner ear, or balance pathways, allowing for tailored treatment as opposed to short-term alleviation.

A significant worldwide disparity in access to specialized neuro-otology care is addressed by NeuroEquilibrium. Through the integration of deep-tech innovation, cloud-based remote platforms, and sophisticated diagnostic tools, it expands precision care outside conventional metropolitan centers, benefiting patients globally and advancing state-of-the-art medical technology.

Also Read: Kayess Square Secures Rs 10 Cr in Pre-Series A Funding Round

NeuroEquilibrium focuses on utilizing technology to address the lack of specialized physicians as it grows across hospitals in India and around the world and develops into chronic lifestyle conditions like diabetes and migraines. Accurate, scalable diagnostics can serve as a force multiplier for improved results and democratize super-specialty healthcare.

NeuroEquilibrium claims to run over 300 clinics in India and 16 other countries, working closely with hospitals, ENT clinics, and neurology centers to enable diagnosis and treatment for over 150,000 patients, greatly improving long-term outcomes.